The latest price target for Astera Labs (NASDAQ:ALAB) was reported by Barclays on May 7, 2026. The analyst firm set a price target for $200.00 expecting ALAB to fall to within 12 months (a possible -13.04% downside). 41 analyst firms have reported ratings in the last year.

The latest analyst rating for Astera Labs (NASDAQ:ALAB) was provided by Barclays, and Astera Labs maintained their equal-weight rating.

The last upgrade for Astera Labs Inc happened on November 17, 2025 when Northland Capital Markets raised their price target to $175. Northland Capital Markets previously had a market perform for Astera Labs Inc.

The last downgrade for Astera Labs Inc happened on October 20, 2025 when Barclays changed their price target from $155 to $155 for Astera Labs Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Astera Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Astera Labs was filed on May 7, 2026 so you should expect the next rating to be made available sometime around May 7, 2027.

While ratings are subjective and will change, the latest Astera Labs (ALAB) rating was a maintained with a price target of $165.00 to $200.00. The current price Astera Labs (ALAB) is trading at is $230.00, which is out of the analyst’s predicted range.